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Oral cancer is a common neoplasm worldwide, 
particularly in developing countries such as India, 
Vietnam and Brazil, where it constitutes up to 25% 
of all types of cancer.1 Despite of the sophisticated 
surgical and radiotherapeutic modalities, the pa-
tient survival has not improved significantly during 
the last decades.2 Tobacco and alcohol consump-
tion are the most significant exogenous factors in-
volved in tumorigenesis.3
The most used animal models in oral cancer 
research  are  the  hamster  buccal  pouch  by  fat-
soluble  7,12  dimethylbenzanthracene  (DMBA), 
and the rat tongue by water-soluble 4-nitroquin-
oline  1-oxide  (4NQO).4  Considering  that  one  of 
the most important routes of oral carcinogens is 
through liquid containing water-soluble carcino-
gens, 4NQO is well suited in examining the role of 
xenobiotics in experimental oral carcinogenesis.5 
Based on the multi-step process of carcinogen-
esis characterized by initiation, promotion and tu-
mor progression, chronic administration of 4NQO 
in drinking water simulates rat tongue carcino-
genesis like human counterpart.6-10
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Moreover,  oral  administration  of  4NQO  pro-
duces  tumor  in  other  tissues  of  oral  cavity  as 
well as aerodigestive tract.11 For example, some 
researchers have described changes induced by 
4NQO intake in minor salivary glands10 and esoph-
ageal mucosa.11 However, to our knowledge, there 
are no studies reporting gingival changes during 
tongue  carcinogenesis  induced  by  4NQO  incor-
porated into drinking water so far. As a result of 
limited evidence, this study was aimed to look at 
putative changes on gingival tissue concomitant 
to tongue carcinogenesis following systemic ex-
posure  to  4NQO.  Certainly,  such  data  will  con-
tribute to a better understanding of this medium-
term oral carcinogenesis assay currently used for 
studying oral cancer pathogenesis.
 
MAtErIAL And MEtHods
Animals and experimental design
A total of 60 male Wistar rats (8 weeks old) 
weighting  approximately  250  g,  were  obtained 
from Centro de Bioterismo (CEMIB), Universidade 
Estadual de Campinas, SP, Brazil. They were main-
tained under controlled conditions of temperature 
(24 ± 2oC), light-dark periods of 12 hours, and with 
free access to water and commercial diet (Nuvital 
PR, Brazil). They were treated with 50 ppm 4NQO 
(Sigma, St. Louis, MO, USA) solution by drinking 
water for 4, 12 and 20 weeks. Thirty animals were 
used as negative control. At the end of the experi-
mental period, the rats were sacrificed by 0.4% 
sodium pentobarbital (1mL/kg body wt, i.p.). The 
final body weight and weight gain were recorded. 
The  tongues  and  mandibles  were  longitudinally 
cut into halves for histopathological examinations. 
For this, the mandibles were decalcified in a 5% of 
nitric acid solution (Merck, Darmstadt, Germany) 
for 5 days. After fixation and/or decalcification, all 
of the tissues were trimmed, dehydrated, cleared, 
embedded  in  paraffin,  sectioned  into  5  µm  tick 
section, stained with hematoxylin and eosin (H.E.) 
All experimental protocols were approved by the 
Animal Committee the Botucatu Medical School, 
UNESP, Brazil.
Histopathological analysis
Histopathological  evaluation  was  performed 
under  light  microscope.  Analyzes  of  the  tongue 
and mandible sections in the molar tooth areas 
were  graded  as  normal,  hyperplasia,  dysplasia 
and carcinoma by Kramer et al.12
Statistical analysis
Results from the final body weight and weight 
gain were analyzed by one way ANOVA, followed 
by Tukey’s test. The level of significance was set 
at 5%.
rEsuLts
Quantitative results
Final body weight and weight gain during the 
experimental  period  are  presented  in  Table  1. 
Excluding 12 weeks treated group for final body 
weight, all groups showed statistically decreases 
(P<.05) either to final body weight or to weight gain 
when compared to control group. 
Morphological results
The dorsal surface of the rats’ tongue treated 
with  4NQO  became  white  with  a  rough  appear-
ance after 12 weeks-treatment only. As time pro-
gressed, ulcers were found in the same region in 
the  majority  of  animals.  No  apparent  abnormal 
clinical signs were noticed to gingival tissue in all 
periods evaluated. 
Regarding  subjective  microscopic  analysis, 
no histopathological changes in tongue epithelia 
were observed in the control group (Figure 1a) nor 
Table 1. Mean±Standard deviation of final body weight and weight gain of rats in the 
4-nitroquinoline 1-oxide (4NQO)a model for oral carcinogenesis.
Dose (ppm) 4 weeks 12 weeks 20 weeks
Final body 
weight
Weight gain
Final body 
weight
Weight gain
Final body 
weight
Weight gain
0 341.56±27.4 45.16±3.12 396.31±54.59 99.91±10.57 462.3±23.46 165.9±18.57
50 273.52±26.5* 6.66±1.04* 314.78±34.34 34.6±5.87* 377.2±60.13* 97.2±20.48*
*:P< .05 when compared to control group (zero).
a4NQO – 50 ppm by drinking water 
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after 4th week treatment with 4NQO. The primary 
histopathological change, i.e., hyperplasia and hy-
perkeratosis with the spinous cell layer gradually 
tickned was evidenced after 12-weeks-treatment 
(Figure 1b). In this period, epithelial dysplasia was 
also found in mild and moderate forms (Figure 1c). 
At 20 weeks, moderate and/or severe oral dyspla-
sia (Figure 1c) and squamous cell carcinoma in 
the tongue (Figure 1d) were found; being that in 
the  majority  of  animals  consisted  of  squamous 
cell carcinoma. The histopathological grade of the 
carcinomas was usually squamous cell carcinoma 
of a well-differentiated type. The tumors spread 
into the submucosa and underlying muscle layer, 
forming small nests with typical keratin pearl for-
mation. In advanced cases, severe atypia was fre-
quently found. The histopathological findings are 
summarized in the Table 2.
Finally, no significant changes were observed 
until 12-weeks of treatment with 4NQO in the gin-
gival mucosa (Figure 2a). However, cases show-
ing  the  presence  of  coarse  food  particles  upon 
gingival  mucosa  producing  inflammation  in  the 
periodontal tissue adjacent the molar tooth were 
noted  sporadically  in  control  and  experimental 
animals (Figure 2b). No significant differences in 
the incidences of gingivitis occurred between con-
trol  and  experimental  groups  (data  not  shown). 
Gingival squamous hyperplasia induced by 4NQO 
after  20-weeks  of  treatment  constituted  a  focal 
lesion that manifested itself in the stratified squa-
mous epithelium of oral mucosa adjacent to molar 
tooth. It consisted of varying degrees of thickening 
of the epithelium showing hyperkeratosis, often 
with the formation of epithelial rete pegs that ex-
tended into the underlying connective tissue (Fig-
ure 2c). Endophytic proliferation of tissue gingival 
squamous hyperplasia occurred most commonly 
rather than exophytic projections in the stratified 
squamous epithelium. The proliferative cells pro-
ducing keratin displayed prominent intercellular 
bridges  and  resembled  normal  stratified  squa-
mous epithelium. In this group, dysplastic changes 
appeared in some animals (two cases) as well. The 
dysplastic cells contained large nuclei with clear 
nucleoli, eosinophilic cytoplasm, mitotic figures, 
and  coexistent  dyskeratotic,  suggesting  cellular 
atypia (Figure 2d). All findings are summarized in 
Table 3.
dIscussIon
The aim of chemical carcinogenesis models is 
to provide further understanding concerning to the 
multi-step process of carcinogenesis in order to 
investigate hazard risk caused by environmental 
agents as well as to develop strategies to earlier 
diagnostic and/or cancer prevention. Several me-
dium-term duration assay systems for oral carci-
Figure 1. Photomicrographies showing the multi-step process 
of rat tongue carcinogenesis. (A) no histopathological change 
(control);  (B)  hyperplasia  and  hyperkeratosis;  (C)  epithelial 
dysplasia; (D) squamous cell carcinoma of  well-differentiated 
type. (Hematoxylin and Eosin stain; X 100 magnification).
Figure 2.  Photomicrographies of gingival tissue from control 
group and that treated with 4NQO. (A) control group, (B) control 
group presenting inflammation (C) hyperplasia and (C) dyspla-
sia. (Hematoxylin and Eosin stain; X 100 magnification).July 2007 - Vol.1
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nogenesis offer particular promise. One of these 
models is DMBA-induced carcinoma produced in 
the hamster cheek pouch. Because of its peculiar 
anatomic site and histology, some authors have 
questioned  the  suitability  of  the  hamster  cheek 
pouch for studies related to oral tumors.13 In this 
regard, the Wistar rat is a good alternative because 
it is ease of handling and availability. Furthermore, 
4NQO-induced rat tongue tumors are more realis-
tic since reveal histological and biochemical char-
acteristics similar to the human tumors.6-10 Such 
results obtained from this present investigation, 
using 4NQO as carcinogen inducers, demonstrat-
ed  histopathological  changes  in  tongue  mucosa 
along a time-course experiment from normal epi-
thelium, hyperplasia and hyperkeratosis, pre-ma-
lignant dysplasia, and carcinoma in situ to invasive 
squamous cell carcinoma.14,15
Accumulating evidence suggests that diagno-
sis of human gingival squamous cell carcinoma 
is prone to delay because it is rare, and thus un-
expected, and because it may be mistaken clini-
cally for gingival or periodontal infection.16 Gingi-
val carcinoma usually occurs in the lower jaw in 
posterior sites with pain, swelling and loosening 
of adjacent teeth being common clinical signs.16 
For this reason, gingival lesions were investigated 
herein within the areas of the lower molar-tooth 
ligament (gingival sulcus). In the rat, the gingiva 
consists of a keratinized stratified squamous epi-
thelium,  connective  tissue  with  fibroblasts,  and 
the  extracellular  matrix,  composed  chiefly  of 
collagen  fibers  and  ground  substance  contain-
ing sulfated glycosaminoglucans.17-19 The gingival 
epithelium in the molar-tooth area is classified as 
gingival oral epithelium, sulcular epithelium and 
junctional  epithelium,  which  appears  non-kera-
tinized and forms the floor of the gingival sulcus. 
Gingival epithelium manifests a higher prolifera-
tive capacity and higher rate of absorption of drugs 
and  chemicals  than  the  skin.18,20  Mitotic  activity 
appears greatest at the dento-gingival junction of 
incisors, especially within the junctional epitheli-
um.21,22 It is important to stress that configuration 
of gingival crevice of molar in rat is different from 
it of human. Therefore, any extrapolation with re-
spect to gingival carcinogenesis in rodents should 
be interpreted catiously.
Taking into consideration that 4NQO requires 
metabolic  activation  to  be  converted  to  the  ul-
timate  carcinogen,  4-acetoxyaminoquinoline 
1-oxide, which reacts with DNA and causes ge-
netic  damage  through  formation  of  alkali  labile 
sites and single strand breaks, absorption of this 
compound  and  subsequent  conversion  by  cyto-
chrome P450 proteins to xenobiotics metabolites 
can occur in gingival epithelia.23 To the best of our 
knowledge, there are no studies that investigated 
Table 2. Incidence of histopathological lesions in tongue of rats in the 4-nitroquinoline 1-oxide (4NQO)a 
model for oral carcinogenesis.
Groups No. of
Lesions    
(week) animals
Normal Hyperplasia Dysplasia Carcinoma
0 (Control) 10 10 0 0 0
4 10 10 0 0 0
12 10 0 7 3 0
20 10 0 0 3 7
a4NQO – 50 ppm by drinking water
Table 3. Histopathological pattern of gingiva following 4-nitroquinoline 1-oxidea administration.
Groups No. of
Lesions (week) animals
Normal Hyperplasia Dysplasia Carcinoma
0 (Control) 10 10 0 0 0
4 10 10 0 0 0
12 10 10 0 0 0
20 10 3 5 2 0
a4NQO – 50 ppm by drinking waterEuropean Journal of Dentistry
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metabolization of 4NQO on gingival tissue. This re-
quires further study. Thus far, the junctional epi-
thelium of molar-tooth, with high proliferative and 
metabolic activity, may change pathologically and 
constitute  the  earliest  gingival  change  induced 
by  4NQO.  Our  results  demonstrated  that  4NQO 
was able to induce gingival changes as depicted 
by squamous gingival hyperplasia after 20 weeks 
following  chronicle  administration.  Additionally, 
some animals pointed out squamous epithelium 
displaying cellular atypia characterized by abnor-
mally differentiated squamous layers usually ac-
companied by thickening of the epithelium. This 
lesion  was  categorized  as  epithelial  dysplasia 
having the potential to progress to squamous cell 
tumours in oral cavity.9 Taken as a whole, we as-
sumed, therefore, that 4NQO was able to induce 
rat gingival changes following tongue carcinogen-
esis. Nevertheless, gingival carcinomas were not 
found in this setting. It is important to stress that 
the  development  of  tongue  carcinoma  following 
4NQO intake was localized mainly to the dorsum 
of the tongue. When animals were consuming the 
carcinogen in drinking water, the 4NQO solution 
might have had intimate contact with the mucosa of 
the dorsum of the tongue, where it could have had 
a direct carcinogenic effect. This may explain the 
effectiveness in the tongue mucosa in this tumor 
producing test system. Conversely, it is conceiv-
able that exposure to 4NQO for a longer period of 
time may have eventually induced squamous cell 
carcinomas. Considering the end-point adopted of 
this study (20 weeks), a strong decrease in weight 
gain was noticed in the experimental group being 
animals deteriorated with subsequent cachexia. In 
this sense, we postulated that longer experimen-
tal design is not feasible for studying rat gingival 
carcinomas. 
concLusIons
Taken together, our results support the notion 
that 4NQO is more effective in rat tongue mucosa 
than  gingival  tissue.  Probably,  this  discrepancy 
depends strongly on route of administration and 
the susceptibility with respect to animals species. 
Certainly,  such  data  will  contribute  when  using 
this experimental test-system for understanding 
oral cancer pathogenesis. Applicability to clinical 
practice for persons at high risk of oral cancer, 
such as in smokers or in alcoholism, as well as 
patients diagnosed with oral dysplasia or carci-
noma, however, remains to be developed.
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